IDSA GUIDELINES Bundle (free trial)

Aspergillosis 2016

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, Enjoy!

Issue link:

Contents of this Issue


Page 23 of 23

Disclaimer is Guideline attempts to define principles of practice that should produce high-quality patient care. It is applicable to specialists, primary care, and providers at all levels. is Guideline should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. e ultimate judgment concerning the propriety of any course of conduct must be made by the clinician aer consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool. Source Patterson TF et al. Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 Jun 29. pii: ciw326. [Epub ahead of print] Abbreviations ABLC, amphotericin B lipid complex; ABPA; allergic bronchopulmonary aspergillosis; AmB, amphotericin B; AML, acute myeloid leukemia; BAL, bronchoalveolar lavage; CCPA, chronic cavitary pulmonary aspergillosis; CF, cystic fibrosis; CGD, chronic granulomatous disease; CNI, calcineurin inhibitors; CNS, central nervous system; CSF, colony-stimulating factor; CT, computed tomography; FEV 1 , forced expiratory volume in one second; G-CSF, granulocyte colony-stimulating factor; GI, gastrointestinal; GM, galactomannan; GM-CSF, granulocyte macrophage colony-stimulating factor; GU, genitourinary; GVHD, gra versus host diseases; HSCT, hematopoietic stem cell transplantation HIV, human immunodeficiency virus; IA, invasive aspergillosis; IFN-γ, interferon gamma; IDSA, Infectious Diseases Society of America; IPA, invasive pulmonary aspergillosis; IV, intravenous; MDS, myelodysplastic syndrome; PCR, polymerase chain reaction; PO, per os; TDM, therapeutic drug monitoring ; TBA; tracheobronchial aspergillosis; TDM, therapeutic drug monitoring ; TNF, tumor necrosis factor 106 Commerce Street, Suite 105 Lake Mary, FL 32746 TEL: 407.878.7606 • FAX: 407.878.7611 For additional copies, order at Copyright © 2016 All rights reserved IDSAASP16073c

Articles in this issue

Links on this page

Archives of this issue

view archives of IDSA GUIDELINES Bundle (free trial) - Aspergillosis 2016